CyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsPhosphoramide MustardsVincristineDoxorubicinAntineoplastic Agents, AlkylatingPrednisoneDrug Administration ScheduleImmunosuppressive AgentsMethotrexatePulse Therapy, DrugTreatment OutcomeEtoposideCombined Modality TherapyEpirubicinBusulfanThiotepaPrednisoloneBreast NeoplasmsRemission InductionAntibodies, Monoclonal, Murine-DerivedFluorouracilLeukopeniaGranulocyte Colony-Stimulating FactorDisease-Free SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinVidarabineTransplantation, AutologousDrug Therapy, CombinationTime FactorsMethylprednisoloneWhole-Body IrradiationCystitisHematopoietic Stem Cell TransplantationAdministration, MetronomicSurvival AnalysisChemotherapy, AdjuvantDose-Response Relationship, DrugSurvival RateCarmustineAntineoplastic AgentsTransplantation ConditioningMelphalanAdministration, OralImmunosuppressionAzathioprineCisplatinWegener GranulomatosisNeutropeniaIfosfamideLupus NephritisMesnaFollow-Up StudiesRecurrenceInfusions, IntravenousChlorambucilMitoxantroneAcroleinBleomycinInjections, IntravenousTransplantation, HomologousLeukocyte CountAlkylating AgentsPaclitaxelHematopoietic Stem Cell MobilizationDexamethasoneProcarbazineCytarabineCarboplatinAnemia, AplasticDrug EvaluationAntibodies, MonoclonalNeoplasm StagingLymphoma, Large B-Cell, DiffuseSpleenProspective StudiesAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisBone MarrowVomitingPrognosisThrombocytopeniaLeukemia, Lymphocytic, Chronic, B-CellLethal Dose 50Graft vs Host DiseaseBiotransformationNeoplasmsClinical Trials as TopicMice, Inbred StrainsTaxoidsMicroscopic PolyangiitisNeoplasm TransplantationRetrospective StudiesMultiple MyelomaRandom AllocationRadiation DosageNauseaNeoadjuvant TherapyLymphomaAmifostine